Randomized controlled trial of interferon- beta-1a in secondary progressive MS: Clinical results. Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-Beta-1a in MS(SPECTRIMS) Study Group Neurology. 2001 Jun 12; 56(11):1496-504. PMID: 11402106. Abstract CommentRecommendBookmarkWatch